Numerous innovations in mobile diagnostic technology, or "labs-on-a-chip," were featured at the recent annual meeting of the American Association for Clinical Chemistry in Chicago.

"Advances in smartphones and biosensors have enabled the development of 'labs-on-a-chip' that can be brought to the patient, instead of the patient being brought to the lab," said AACC officials. "This technology is creating a paradigm shift in healthcare delivery that will make it much easier for patients to undergo clinical testing and get the treatment they need, and could be especially beneficial for patients in resource-limited or remote settings who don’t have access to a hospital."

New mobile diagnostic and lab-on-a-chip technology found at AACC’s meeting included:

*A smartphone-based HRDR-200 Rapid Diagnostic Reader by Holomic. This handheld, mobile tool can serve as a portable “smartphone lab” for the diagnosis of thyroid disorders, infectious diseases, and other common health conditions.

*A biochip platform by OJ-Bio, which uses surface acoustic wave technology and a hand-held reader connected to a smartphone to test for multiple biomarkers simultaneously. These biochips are currently being developed to diagnose HIV, respiratory disease, and periodontal disease.

*A portable, one-step molecular diagnostic system by Coyote Bioscience, which is designed to bring complex genetic testing directly to the patient.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access